Celltrion Is Latest To File Eylea Rival In US

Korean Firm Submits Application For CT-P42 Aflibercept Biosimilar To US FDA

 
• By David Wallace
  
perfect blue eye macro in a sterile environment and perfect vision in resolution 6k, concept, the vision of the future and healthy life concept. view precise and straight to the target.
Celltrion has submitted its Eylea biosimilar to the FDA • Source: Shutterstock

More from Biosimilars

More from Products